Evidence map›Paper›PMID 39266672›Full record

Trial reportSpinal cord2024

A home-based self-directed EEG neurofeedback intervention for people with chronic neuropathic pain following spinal cord injury (the StoPain Trial): description of the intervention.

Negin Hesam-Shariati, Lara Alexander, Kevin Yi Chen, Ashley Craig, Paul A Glare, Mark P Jensen, Chin-Teng Lin, James H McAuley, James W Middleton, G Lorimer Moseley and 5 more

Abstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Spinal cord, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Negin Hesam-ShariatiNeuroRecovery Research Hub, School of Psychology, University of New South Wales, Sydney, NSW, Australia. n.hesamshariati@neura.edu.au.ORCID 0000-0003-0829-7016
Lara AlexanderNeuroRecovery Research Hub, School of Psychology, University of New South Wales, Sydney, NSW, Australia.
Kevin Yi ChenNeuroRecovery Research Hub, School of Psychology, University of New South Wales, Sydney, NSW, Australia.
Ashley CraigThe Kolling Institute, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.ORCID 0000-0001-7647-7604
Paul A GlareNorthern Clinical School, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.
Mark P JensenDepartment of Rehabilitation Medicine, University of Washington, Seattle, WA, USA.
Chin-Teng LinCIBCI Lab, Human-centric Artificial Intelligence Centre, Australian AI Institute, FEIT, University of Technology Sydney, Sydney, NSW, Australia.
James H McAuleyCentre for Pain IMPACT, Neuroscience Research Australia, Sydney, NSW, Australia.
James W MiddletonThe Kolling Institute, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.ORCID 0000-0002-2777-8619
G Lorimer MoseleyIIMPACT in Health, University of South Australia, Kuarna Country, Adelaide, SA, Australia.
Toby Newton-JohnGraduate School of Health, University of Technology Sydney, Sydney, NSW, Australia.
Sebastian RestrepoNeuroRecovery Research Hub, School of Psychology, University of New South Wales, Sydney, NSW, Australia.
Ian W SkinnerGraduate School of Health, University of Technology Sydney, Sydney, NSW, Australia.
Pauline ZaharaNeuroRecovery Research Hub, School of Psychology, University of New South Wales, Sydney, NSW, Australia.
Sylvia M GustinNeuroRecovery Research Hub, School of Psychology, University of New South Wales, Sydney, NSW, Australia.

Funding

Department of Health | National Health and Medical Research Council (NHMRC) 2001653Department of Health | National Health and Medical Research Council (NHMRC) 2021183
6 · The paper itself

Abstract

STUDY

designRandomised controlled trial.

objectivesThe objective is to describe an electroencephalography (EEG) neurofeedback intervention that will be provided in a randomised controlled trial for people with neuropathic pain following spinal cord injury (SCI): the StoPain Trial. In this trial, participants in the treatment group will implement an EEG neurofeedback system as an analgesic intervention at home, while participants in the control group will continue with the treatments available to them in the community.

settingUniversity-based study in Sydney, Australia. METHODS/

resultsThis manuscript describes the rationale and components of the EEG neurofeedback intervention designed for individuals with SCI neuropathic pain and intended for home-based implementation. Our report is based on the criteria of the Template for Intervention Description and Replication (TIDieR) checklist, and includes why the efficacy of EEG neurofeedback will be investigated, what will be provided, who will administer it, and how, where, when, and how much the EEG neurofeedback intervention will be administered.

conclusionsThis manuscript provides a detailed description of a complex intervention used in a randomised controlled trial. This description will facilitate the subsequent interpretation of the trial results and allow for the replication of the intervention in clinical practice and future trials. SPONSORSHIP: Australian Government Medical Research Future Fund (2020 Rare Cancers Rare Diseases and Unmet Needs Scheme: 2006020).

Indexed as

ElectroencephalographyNeuralgiaNeurofeedbackSpinal Cord InjuriesChronic PainHome Care ServicesHumans

Identifiers

PMID39266672
PMCPMC11549037

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.